Chronic Pain News

Migraines affect roughly 850,000 Minnesotans. Here is what clinical research says about cannabis for acute migraine relief and prevention, including drug interactions with triptans, beta-blockers, topiramate, and valproate, and how to qualify for the medical cannabis program.

Osteoarthritis and rheumatoid arthritis involve different mechanisms and respond differently to cannabis. This 2026 guide covers the endocannabinoid system in joint tissue, clinical evidence, drug interactions with methotrexate and JAK inhibitors, product recommendations by arthritis type, and how Minnesota patients can qualify for a medical card.

Adults 65 and older are the fastest-growing cannabis consumer segment. This guide covers how aging changes your cannabis experience, the strongest evidence for chronic pain, arthritis, sleep, and anxiety, drug interactions seniors must know (warfarin, blood thinners, sedatives), best product types, dosing guidance, Minnesota qualifying conditions for a medical card, and how to navigate a dispensary for the first time.

Microdosing means taking 1 to 5mg of THC for therapeutic benefit without meaningful intoxication. Here is how to find your minimum effective dose, which products to use, and what Minnesota law says.

Chronic pain and intractable pain qualify for Minnesota's medical cannabis card. Here is what research supports, which products work best for different pain types, and how to use cannabis alongside conventional treatment.